The FDA has unveiled two draft guidance documents for products seeking investigational device exemption. The first details new feasibility research approaches to guide a product's final design better and enable studies to start sooner, while the second describes the process for approving clinical trials. The agency also launched an amended standard operating procedure for obtaining new data from devices undergoing premarket evaluation.
Draft rules on investigational device exemption trials unveiled
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan